CRHM - CRH Medical Corporation

NYSE American - Nasdaq Real Time Price. Currency in USD

CRH Medical Corporation

World Trade Center
Suite 578 999 Canada Place
Vancouver, BC V6C 3E1
Canada
800-660-2153
http://investors.crhsystem.com

Sector
Industry
Full Time Employees112

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard K. BearCFO & Corp. Sec.490kN/A1963
Mr. James T. KregerPres of CRH Anesthesia Management353.53kN/A1969
Dr. Tushar M. RamaniCEO & DirectorN/AN/A1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Corporate Governance

CRH Medical Corporation’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 1; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.